# FDA 483 - George A. Diaz, M.D. - July 17, 2020

Source: https://www.globalkeysolutions.net/records/483/george-a-diaz-md/1b6d08fb-3d64-412f-ad38-bdd1f199ff7a

> FDA 483 for George A. Diaz, M.D. on July 17, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: George A. Diaz, M.D.
- Inspection Date: 2020-07-17
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West VI
- Summary: An FDA inspection of George A. Diaz, MD, Infectious Disease Hospitalist in Everett, WA, revealed a significant deficiency in conducting an investigation. The firm failed to report a serious adverse event (SAE) within the timeframe specified by the protocol and investigational plan. This lapse involved a subject experiencing a potentially life-threatening decrease in estimated glomerular filtration rate (eGFR).

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.globalkeysolutions.net/companies/george-a-diaz-md/5bfa39bb-1caa-41e0-8f3d-a40591715419

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-vi/6e5a2a08-f464-4979-a759-7b0383370822